Pasithea Therapeutics Announces PAS-004 Abstract Accepted for Poster Presentation at 2024 ASCO Annual Meeting
29 avr. 2024 07h59 HE
|
Pasithea
Pasithea Therapeutics' PAS-004 abstract accepted for ASCO poster presentation: novel MEK inhibitor shows promise for NF1 and cancer therapy.
Pasithea Therapeutics Announces the First Cohort has Completed the Initial Dosing in its Phase 1 Trial Evaluating PAS-004 in RAS, NF1 and RAF Mutated Cancers
24 avr. 2024 07h59 HE
|
Pasithea
Pasithea Tx (Nasdaq: KTTA) Phase 1 trial on PAS-004 for RAS, NF1, and RAF mutated cancers completes initial dosing, with safety data expected in 2H 2024.
Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer Xenograft Models
11 déc. 2023 08h01 HE
|
Pasithea
Pasithea Therapeutics (Nasdaq: KTTA) announced positive preclinical efficacy in models conducted ahead of its planned Phase I, in-human trials in 1Q24.
Pasithea Therapeutics Announces Outcome of Pre-IND Meeting with FDA for PAS-004 Clinical Development
29 nov. 2023 07h59 HE
|
Pasithea
Pasithea Therapeutics Discusses Outcome of Pre-IND Meeting with FDA for Clinical Development of its MEK inhibitor, PAS-004
Pasithea Therapeutics Abstract Accepted for Poster Presentation at 2023 Neurofibromatosis Conference
01 juin 2023 07h57 HE
|
Pasithea
PALO ALTO, Calif. and MIAMI, June 01, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research,...
Media Alert: Innovative Business Opportunities in Neurofibromatosis
09 juin 2014 10h19 HE
|
Children's Tumor Foundation
NEW YORK, N.Y., June 9, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation (CTF) is hosting the 2014 NF Conference, the largest worldwide meeting dedicated entirely to neurofibromatosis (NF), a...
KEY MEDIA OPPORTUNITIES AT THE 2014 NF FORUM/CONFERENCE
06 juin 2014 16h54 HE
|
Children's Tumor Foundation
-- NIH Director Francis Collins to Deliver Keynote Address
-- First-ever 'Business Opportunities in NF' Satellite Meeting
NEW YORK, June 6, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor...
World's Largest Neurofibromatosis Conference to be Held in Washington, D.C.
03 juin 2014 16h52 HE
|
Children's Tumor Foundation
NEW YORK, June 3, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation (CTF) is hosting the 2014 NF Conference/Forum, the largest worldwide meeting dedicated entirely to neurofibromatosis (NF), a...
Children's Tumor Foundation Announces Historic New Initiative in Neurofibromatosis Research
10 mars 2014 11h33 HE
|
Children's Tumor Foundation
NEW YORK, March 10, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation, the leading non-governmental organization dedicated to neurofibromatosis (NF) research, announced today an important new...
Children's Tumor Foundation Announces Leadership Change
15 janv. 2014 14h16 HE
|
Children's Tumor Foundation
NEW YORK, Jan. 15, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation (CTF) announced today that Annette Bakker, Chief Scientific Officer of the Foundation has been elevated to President,...